IgA nephropathy presenting as rapidly progressive glomerulonephritis following first dose of COVID-19 vaccine

Pediatr Nephrol. 2022 Feb;37(2):461-462. doi: 10.1007/s00467-021-05351-x. Epub 2021 Nov 16.

Authors

Olivier Niel^{1

2}, Cosmin Florescu³

Affiliations

¹ Pediatric Nephrology, Centre Hospitalier de Luxembourg, 5 rue Barblé, L1210, Luxembourg, Luxembourg. niel.olivier@chl.lu.
² Faculty of Science, Technology and Medicine, University of Luxembourg, 2 Avenue de l'Université, L4365, Esch-sur-Alzette, Luxembourg. niel.olivier@chl.lu.
³ National Center of Pathology, Laboratoire National de Santé, 1 rue Rech, L3555, Dudelange, Luxembourg.

No abstract available

Publication types

Letter

MeSH terms

COVID-19 / prevention & control*
COVID-19 Vaccines / administration & dosage
COVID-19 Vaccines / adverse effects*
Glomerulonephritis / chemically induced*
Glomerulonephritis / diagnosis
Glomerulonephritis, IGA / drug therapy
Glomerulonephritis, IGA / pathology*
Hematuria / etiology
Humans
Immunoglobulin A / analysis
SARS-CoV-2

Substances

COVID-19 Vaccines
Immunoglobulin A